Adenocarcinoma of the Pancreas Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03871959Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic AdenocarcinomaTreatment
NCT02376699Safety Study of SEA-CD40 in Cancer PatientsTreatment
NCT02675946CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab in Subjects With Advanced GI Tumors (Keynote 596)Treatment